Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.94 CAD
−37.16 M CAD
85.13 M CAD
31.55 M
About HLS THERAPEUTICS INC
Sector
CEO
Craig Millian
Headquarters
Etobicoke
Website
Founded
2014
FIGI
BBG000BXJ2X3
HLS Therapeutics, Inc.e ngages in commercializing pharmaceutical products. It specializes in central nervous system and cardiovascular markets. The company was founded by Gregory Gubitz and Gilbert Godin on June 5, 2014 and is headquartered in Etobicoke, Canada.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HLS is 3.65 CAD — it has decreased by −1.35% in the past 24 hours. Watch HLS THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange HLS THERAPEUTICS INC stocks are traded under the ticker HLS.
HLS stock has risen by 7.35% compared to the previous week, the month change is a −6.41% fall, over the last year HLS THERAPEUTICS INC has showed a −24.27% decrease.
We've gathered analysts' opinions on HLS THERAPEUTICS INC future price: according to them, HLS price has a max estimate of 9.50 CAD and a min estimate of 3.28 CAD. Watch HLS chart and read a more detailed HLS THERAPEUTICS INC stock forecast: see what analysts think of HLS THERAPEUTICS INC and suggest that you do with its stocks.
HLS stock is 7.84% volatile and has beta coefficient of 0.51. Track HLS THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is HLS THERAPEUTICS INC there?
Today HLS THERAPEUTICS INC has the market capitalization of 116.04 M, it has decreased by −11.46% over the last week.
Yes, you can track HLS THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
HLS THERAPEUTICS INC is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
HLS earnings for the last quarter are −0.20 CAD per share, whereas the estimation was −0.17 CAD resulting in a −20.12% surprise. The estimated earnings for the next quarter are −0.14 CAD per share. See more details about HLS THERAPEUTICS INC earnings.
HLS THERAPEUTICS INC revenue for the last quarter amounts to 19.06 M CAD, despite the estimated figure of 19.78 M CAD. In the next quarter, revenue is expected to reach 21.57 M CAD.
HLS net income for the last quarter is −6.61 M CAD, while the quarter before that showed −7.77 M CAD of net income which accounts for 15.02% change. Track more HLS THERAPEUTICS INC financial stats to get the full picture.
As of Nov 10, 2024, the company has 91.00 employees. See our rating of the largest employees — is HLS THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HLS THERAPEUTICS INC EBITDA is 21.57 M CAD, and current EBITDA margin is 34.23%. See more stats in HLS THERAPEUTICS INC financial statements.
Like other stocks, HLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HLS THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HLS THERAPEUTICS INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HLS THERAPEUTICS INC stock shows the sell signal. See more of HLS THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.